Copyright Reports & Markets. All rights reserved.

Global CT Guided Intervention Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of CT Guided Intervention by Type
    • 1.3.1 Overview: Global CT Guided Intervention Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global CT Guided Intervention Consumption Value Market Share by Type in 2025
    • 1.3.3 CT Navigation Systems
    • 1.3.4 Needle Guidance Systems
    • 1.3.5 Needle Positioning Systems
    • 1.3.6 Fluoroscopy Systems
    • 1.3.7 Other
  • 1.4 Classification of CT Guided Intervention by Mobility Type
    • 1.4.1 Overview: Global CT Guided Intervention Market Size by Mobility Type: 2021 Versus 2025 Versus 2032
    • 1.4.2 Global CT Guided Intervention Consumption Value Market Share by Mobility Type in 2025
    • 1.4.3 Fixed Systems
    • 1.4.4 Mobile Systems
    • 1.4.5 Portable Systems
  • 1.5 Classification of CT Guided Intervention by Clinical Application
    • 1.5.1 Overview: Global CT Guided Intervention Market Size by Clinical Application: 2021 Versus 2025 Versus 2032
    • 1.5.2 Global CT Guided Intervention Consumption Value Market Share by Clinical Application in 2025
    • 1.5.3 Lung Cancer
    • 1.5.4 Liver Cancer
    • 1.5.5 Bone Lesions
    • 1.5.6 Others
  • 1.6 Global CT Guided Intervention Market by Application
    • 1.6.1 Overview: Global CT Guided Intervention Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.6.2 Hospitals
    • 1.6.3 Ambulatory Surgical Centers
    • 1.6.4 Other
  • 1.7 Global CT Guided Intervention Market Size & Forecast
  • 1.8 Global CT Guided Intervention Market Size and Forecast by Region
    • 1.8.1 Global CT Guided Intervention Market Size by Region: 2021 VS 2025 VS 2032
    • 1.8.2 Global CT Guided Intervention Market Size by Region, (2021-2032)
    • 1.8.3 North America CT Guided Intervention Market Size and Prospect (2021-2032)
    • 1.8.4 Europe CT Guided Intervention Market Size and Prospect (2021-2032)
    • 1.8.5 Asia-Pacific CT Guided Intervention Market Size and Prospect (2021-2032)
    • 1.8.6 South America CT Guided Intervention Market Size and Prospect (2021-2032)
    • 1.8.7 Middle East & Africa CT Guided Intervention Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Siemens Healthineers
    • 2.1.1 Siemens Healthineers Details
    • 2.1.2 Siemens Healthineers Major Business
    • 2.1.3 Siemens Healthineers CT Guided Intervention Product and Solutions
    • 2.1.4 Siemens Healthineers CT Guided Intervention Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Siemens Healthineers Recent Developments and Future Plans
  • 2.2 CANON MEDICAL
    • 2.2.1 CANON MEDICAL Details
    • 2.2.2 CANON MEDICAL Major Business
    • 2.2.3 CANON MEDICAL CT Guided Intervention Product and Solutions
    • 2.2.4 CANON MEDICAL CT Guided Intervention Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 CANON MEDICAL Recent Developments and Future Plans
  • 2.3 Philips
    • 2.3.1 Philips Details
    • 2.3.2 Philips Major Business
    • 2.3.3 Philips CT Guided Intervention Product and Solutions
    • 2.3.4 Philips CT Guided Intervention Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Philips Recent Developments and Future Plans
  • 2.4 GE Healthcare
    • 2.4.1 GE Healthcare Details
    • 2.4.2 GE Healthcare Major Business
    • 2.4.3 GE Healthcare CT Guided Intervention Product and Solutions
    • 2.4.4 GE Healthcare CT Guided Intervention Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 GE Healthcare Recent Developments and Future Plans
  • 2.5 Hologic
    • 2.5.1 Hologic Details
    • 2.5.2 Hologic Major Business
    • 2.5.3 Hologic CT Guided Intervention Product and Solutions
    • 2.5.4 Hologic CT Guided Intervention Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Hologic Recent Developments and Future Plans
  • 2.6 BD
    • 2.6.1 BD Details
    • 2.6.2 BD Major Business
    • 2.6.3 BD CT Guided Intervention Product and Solutions
    • 2.6.4 BD CT Guided Intervention Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 BD Recent Developments and Future Plans
  • 2.7 Cook Medical
    • 2.7.1 Cook Medical Details
    • 2.7.2 Cook Medical Major Business
    • 2.7.3 Cook Medical CT Guided Intervention Product and Solutions
    • 2.7.4 Cook Medical CT Guided Intervention Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Cook Medical Recent Developments and Future Plans
  • 2.8 Boston Scientific
    • 2.8.1 Boston Scientific Details
    • 2.8.2 Boston Scientific Major Business
    • 2.8.3 Boston Scientific CT Guided Intervention Product and Solutions
    • 2.8.4 Boston Scientific CT Guided Intervention Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Boston Scientific Recent Developments and Future Plans
  • 2.9 Mindray
    • 2.9.1 Mindray Details
    • 2.9.2 Mindray Major Business
    • 2.9.3 Mindray CT Guided Intervention Product and Solutions
    • 2.9.4 Mindray CT Guided Intervention Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Mindray Recent Developments and Future Plans
  • 2.10 United Imaging
    • 2.10.1 United Imaging Details
    • 2.10.2 United Imaging Major Business
    • 2.10.3 United Imaging CT Guided Intervention Product and Solutions
    • 2.10.4 United Imaging CT Guided Intervention Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 United Imaging Recent Developments and Future Plans
  • 2.11 Neusoft Medical
    • 2.11.1 Neusoft Medical Details
    • 2.11.2 Neusoft Medical Major Business
    • 2.11.3 Neusoft Medical CT Guided Intervention Product and Solutions
    • 2.11.4 Neusoft Medical CT Guided Intervention Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Neusoft Medical Recent Developments and Future Plans
  • 2.12 Wandong Medical
    • 2.12.1 Wandong Medical Details
    • 2.12.2 Wandong Medical Major Business
    • 2.12.3 Wandong Medical CT Guided Intervention Product and Solutions
    • 2.12.4 Wandong Medical CT Guided Intervention Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Wandong Medical Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global CT Guided Intervention Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of CT Guided Intervention by Company Revenue
    • 3.2.2 Top 3 CT Guided Intervention Players Market Share in 2025
    • 3.2.3 Top 6 CT Guided Intervention Players Market Share in 2025
  • 3.3 CT Guided Intervention Market: Overall Company Footprint Analysis
    • 3.3.1 CT Guided Intervention Market: Region Footprint
    • 3.3.2 CT Guided Intervention Market: Company Product Type Footprint
    • 3.3.3 CT Guided Intervention Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global CT Guided Intervention Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global CT Guided Intervention Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global CT Guided Intervention Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global CT Guided Intervention Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America CT Guided Intervention Consumption Value by Type (2021-2032)
  • 6.2 North America CT Guided Intervention Market Size by Application (2021-2032)
  • 6.3 North America CT Guided Intervention Market Size by Country
    • 6.3.1 North America CT Guided Intervention Consumption Value by Country (2021-2032)
    • 6.3.2 United States CT Guided Intervention Market Size and Forecast (2021-2032)
    • 6.3.3 Canada CT Guided Intervention Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico CT Guided Intervention Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe CT Guided Intervention Consumption Value by Type (2021-2032)
  • 7.2 Europe CT Guided Intervention Consumption Value by Application (2021-2032)
  • 7.3 Europe CT Guided Intervention Market Size by Country
    • 7.3.1 Europe CT Guided Intervention Consumption Value by Country (2021-2032)
    • 7.3.2 Germany CT Guided Intervention Market Size and Forecast (2021-2032)
    • 7.3.3 France CT Guided Intervention Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom CT Guided Intervention Market Size and Forecast (2021-2032)
    • 7.3.5 Russia CT Guided Intervention Market Size and Forecast (2021-2032)
    • 7.3.6 Italy CT Guided Intervention Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific CT Guided Intervention Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific CT Guided Intervention Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific CT Guided Intervention Market Size by Region
    • 8.3.1 Asia-Pacific CT Guided Intervention Consumption Value by Region (2021-2032)
    • 8.3.2 China CT Guided Intervention Market Size and Forecast (2021-2032)
    • 8.3.3 Japan CT Guided Intervention Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea CT Guided Intervention Market Size and Forecast (2021-2032)
    • 8.3.5 India CT Guided Intervention Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia CT Guided Intervention Market Size and Forecast (2021-2032)
    • 8.3.7 Australia CT Guided Intervention Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America CT Guided Intervention Consumption Value by Type (2021-2032)
  • 9.2 South America CT Guided Intervention Consumption Value by Application (2021-2032)
  • 9.3 South America CT Guided Intervention Market Size by Country
    • 9.3.1 South America CT Guided Intervention Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil CT Guided Intervention Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina CT Guided Intervention Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa CT Guided Intervention Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa CT Guided Intervention Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa CT Guided Intervention Market Size by Country
    • 10.3.1 Middle East & Africa CT Guided Intervention Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey CT Guided Intervention Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia CT Guided Intervention Market Size and Forecast (2021-2032)
    • 10.3.4 UAE CT Guided Intervention Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 CT Guided Intervention Market Drivers
  • 11.2 CT Guided Intervention Market Restraints
  • 11.3 CT Guided Intervention Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 CT Guided Intervention Industry Chain
  • 12.2 CT Guided Intervention Upstream Analysis
  • 12.3 CT Guided Intervention Midstream Analysis
  • 12.4 CT Guided Intervention Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global CT Guided Intervention market size was valued at US$ 709 million in 2025 and is forecast to a readjusted size of US$ 1095 million by 2032 with a CAGR of 6.4% during review period.
    CT Guided Intervention refers to a category of precision interventional medical procedures performed under real-time or staged Computed Tomography (CT) imaging guidance, including puncture, biopsy, ablation, drainage, drug injection, and minimally invasive therapeutic operations. By utilizing high-resolution tomographic imaging to accurately identify lesions, surrounding vessels, and tissue structures, this technology significantly improves the precision and safety of complex procedures. It is widely applied in tumor intervention, lung nodule biopsy, liver and kidney ablation, spinal therapy, and pain management. Driven by the rapid development of precision medicine, minimally invasive surgery, and early cancer screening programs, CT-guided intervention is evolving from a traditional imaging support tool into an integrated medical solution combining diagnosis, treatment, and real-time procedural assessment. In recent years, advancements in artificial intelligence image recognition, robotic navigation systems, 3D reconstruction, and low-dose scanning technologies have further accelerated the transition of CT Guided Intervention toward intelligent, precise, and integrated clinical applications, making it one of the key growth segments in modern interventional medicine and high-end medical equipment industries.
    The increasing incidence of cancer, rapid adoption of minimally invasive treatment concepts, and expansion of precision medicine systems are driving the CT Guided Intervention market into a strong growth cycle. Compared with conventional open surgery, CT-guided intervention offers advantages such as reduced trauma, faster recovery, precise targeting, and lower complication risks, making it highly attractive to major hospitals, oncology centers, and regional healthcare institutions. In recent years, government support for early cancer screening, hierarchical healthcare systems, and domestic high-end medical equipment development has further strengthened market momentum. At the same time, the integration of AI-assisted diagnosis, interventional navigation systems, and robotic technologies is transforming CT Guided Intervention into an intelligent treatment platform, significantly enhancing clinical efficiency and complex lesion management capabilities.
    Despite strong growth potential, the CT Guided Intervention industry still faces challenges including high equipment investment costs, long physician training cycles, and uneven distribution of medical resources across regions. Advanced CT interventional systems require high imaging precision, sophisticated software algorithms, and real-time navigation capabilities, creating substantial technical barriers and increasing market entry thresholds. In addition, some regional healthcare institutions still lack sufficient interventional experience, imaging coordination capabilities, and post-procedure management systems, limiting broader adoption of advanced intervention technologies. As global healthcare regulations become more stringent, rising requirements for product registration, clinical validation, and radiation safety standards are also increasing pressure on R&D investment and international expansion strategies. Future competition will increasingly focus on imaging intelligence, clinical integration, and comprehensive solution capabilities.
    Downstream demand is evolving from traditional tumor biopsy and puncture procedures toward precision ablation, pain therapy, vascular intervention, and complex minimally invasive treatments. Growing demand for lung nodule screening, early liver cancer diagnosis, and chronic pain management is significantly increasing hospital demand for high-precision CT intervention systems and related consumables. Meanwhile, patients are placing greater emphasis on minimally invasive procedures, treatment precision, and faster post-operative recovery, accelerating the adoption of outpatient interventional therapy and precision navigation treatment models. The integration of AI-based 3D reconstruction, real-time path planning, and remote collaborative intervention technologies is also driving the industry from a standalone imaging equipment market toward a fully digital interventional platform ecosystem, creating new growth opportunities for high-end medical device manufacturers.
    This report is a detailed and comprehensive analysis for global CT Guided Intervention market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global CT Guided Intervention market size and forecasts, in consumption value ($ Million), 2021-2032
    Global CT Guided Intervention market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global CT Guided Intervention market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global CT Guided Intervention market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for CT Guided Intervention
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global CT Guided Intervention market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Siemens Healthineers, CANON MEDICAL, Philips, GE Healthcare, Hologic, BD, Cook Medical, Boston Scientific, Mindray, United Imaging, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    CT Guided Intervention market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    CT Navigation Systems
    Needle Guidance Systems
    Needle Positioning Systems
    Fluoroscopy Systems
    Other
    Market segment by Mobility Type
    Fixed Systems
    Mobile Systems
    Portable Systems
    Market segment by Clinical Application
    Lung Cancer
    Liver Cancer
    Bone Lesions
    Others
    Market segment by Application
    Hospitals
    Ambulatory Surgical Centers
    Other
    Market segment by players, this report covers
    Siemens Healthineers
    CANON MEDICAL
    Philips
    GE Healthcare
    Hologic
    BD
    Cook Medical
    Boston Scientific
    Mindray
    United Imaging
    Neusoft Medical
    Wandong Medical
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe CT Guided Intervention product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of CT Guided Intervention, with revenue, gross margin, and global market share of CT Guided Intervention from 2021 to 2026.
    Chapter 3, the CT Guided Intervention competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and CT Guided Intervention market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of CT Guided Intervention.
    Chapter 13, to describe CT Guided Intervention research findings and conclusion.

    Buy now